Meropenem Aurovit

Meropenem, the active ingredient in Meropenem Aurovit, is a carbapenem antibiotic presented as an injection powder for solution for infusion for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, meningitis, and other serious infections in hospitalized patients.

GNH USA supplies Meropenem Aurovit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on reliable cold‑chain logistics and regulatory compliance, ensuring timely delivery to patients.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: effective bacterial eradication in severe abdominal infections. - Complicated urinary tract infections: clears resistant uropathogens in complicated cases. - Hospital‑acquired pneumonia: combats multidrug‑resistant organisms causing nosocomial pneumonia. - Ventilator‑associated pneumonia: provides coverage for pathogens associated with mechanical ventilation. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. - Septicemia: rapidly reduces bacterial load in bloodstream infections.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may occur during therapy. - Infusion site phlebitis: irritation at the IV site. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Seizures: risk increases with high doses or renal impairment. - Clostridioides difficile‑associated colitis: severe diarrhea due to bacterial overgrowth. - Anaphylactic reaction: acute hypersensitivity requiring immediate medical attention.

Meropenem should be used with careful clinical monitoring. - Assess renal function: adjust dosing in renal impairment. - Monitor hepatic enzymes: watch for liver function changes. - Adjust dose in renal impairment: follow prescriber guidance. - Use with caution in patients with CNS disorders: increased seizure risk. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several concomitant medications.

Major Interactions (Avoid): - Valproic acid: carbapenems can reduce serum valproate levels, risking seizure breakthrough. - Other nephrotoxic agents (e.g., aminoglycosides): combined use may increase renal toxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - NSAIDs: may affect renal clearance, requiring renal monitoring. - Warfarin: observe INR for potential anticoagulation changes.